Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 38 EP applications Edward Christopher Oates has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11855817

PROCESS FOR PREPARING ALDITOL ACETALS

IPC classification:
B01J 31/02, C07C 41/48, C07D 493/04
Applicant:
Reliance Industries Ltd
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12712440

PROTEASOME INHIBITOR DELANZOMIB FOR USE IN THE TREATMENT OF LUPUS

IPC classification:
A61K 45/06, A61K 31/69, A61P 37/00, A61P 17/00
Applicant:
Cephalon Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12709179

FLUORO-PYRIDINONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS

IPC classification:
A61K 31/4439, A61K 31/4433, A61K 31/4427, A61K 31/4412, C07D 417/12, C07D 413/10, C07D 405/12, C07D 405/04, C07D 401/10, C07D 401/04, C07D 213/69, C07D 213/64, A61P 31/00
Applicant:
Pfizer Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Pfizer Inc
Status:
PATENT GRANTED
EP12711303

MACROCYCLIC COMPOUNDS AS ALK, FAK AND JAK2 INHIBITORS

IPC classification:
C07D 487/08
Applicant:
Cephalon Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12713369

IMIDAZOLE, PYRAZOLE, AND TRIAZOLE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS

IPC classification:
A61K 31/4192, C07D 417/04, C07D 413/10, C07D 413/04, C07D 405/04, C07D 403/04, C07D 249/06, C07D 233/61, C07D 231/12, A61P 31/04
Applicant:
Pfizer Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Pfizer Inc
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12730349

PROTEASOME INHIBITORS AND PROCESSES FOR THEIR PREPARATION, PURIFICATION AND USE

IPC classification:
A61K 31/69, C07F 5/02
Applicant:
Cephalon Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12710841

MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

IPC classification:
A61K 31/424, C07D 498/10, A61P 29/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Kristina Cornish, Kilburn & Strode LLP
Status:
PATENT GRANTED
EP14163968

Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters

IPC classification:
A61K 31/443, C07D 405/12, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12794811

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

IPC classification:
A61K 31/553, A61K 31/405, C07D 498/04, C07D 405/14, C07D 405/12, A61P 35/00, A61P 27/00, A61P 25/00, A61P 11/00, A61P 3/00, A61P 1/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14168373

Modulators of CFTR

IPC classification:
A61K 31/444, C07D 405/14, C07D 401/04, A61P 37/00, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12716624

ISOXAZOLE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS

IPC classification:
A61K 31/422, A61K 31/42, A61K 31/04, C07D 413/04, C07D 261/08
Applicant:
Pfizer Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Pfizer Inc
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12787303

USE OF (N- [2, 4 -BIS (1, 1 -DIMETHYLETHYL) - 5 - HYDROXYPHENYL]- 1, 4 - DIHYDRO - 4 - OXOQUINOLINE - 3 - CARBOXAMIDE) FOR TREATING CFTR MEDIATED DISEASES

IPC classification:
A61K 31/47
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14184159

Compositions for treatment of cystic fibrosis and other chronic diseases

IPC classification:
A61K 45/06, A61K 31/501, A61K 31/4965, A61K 31/443, A61K 31/404, A61P 43/00, A61P 19/10, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13706858

METHODS FOR TREATING AN IMPAIRMENT IN GAIT AND/OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AN AMINOPYRIDINE

IPC classification:
A61K 31/505, A61P 25/14
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13749829

FORMULATIONS OF BENDAMUSTINE

IPC classification:
A61K 31/4184, A61P 35/00
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Olga Capasso, De Simone & Partners Spa
Status:
EXAMINATION IN PROGRESS
EP14182117

Process for making modulators of cystic fibrosis transmembrane conductance regulator

IPC classification:
C07D 215/233
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14164892

Azaindole derivatives as CFTR modulators

IPC classification:
A61K 31/437, C07D 471/04, A61P 25/00, A61P 3/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14172991

Solid amorphous form of (R)-1(2,2-difluorobenzo(D)(1,3)dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)-cyclopropanecarboxamide

IPC classification:
A61K 31/404, C07D 405/12, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13764989

FORMULATIONS OF BENDAMUSTINE

IPC classification:
A61K 31/4184
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Olga Capasso, De Simone & Partners Spa
Status:
GRANT OF PATENT INTENDED
EP13765020

METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION

IPC classification:
A61K 31/4184
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Olga Capasso, De Simone & Partners Spa
Status:
GRANT OF PATENT INTENDED
EP13731230

METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN

IPC classification:
A61K 31/517, A61K 31/513, A61K 31/4745, A61K 9/00, A61P 35/00
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
PATENT GRANTED
EP13860427

COMBINATION THERAPY FOR TREATING HER2-POSITIVE CANCERS

IPC classification:
A61K 39/395, A61K 9/127, A61P 35/00
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Deborah Mary Hart, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP13826678

3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS

IPC classification:
A61K 31/4965, C07D 241/20, A61P 11/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13814392

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES FAVOURED BY INSUFFICIENT MUCOSAL HYDRATION

IPC classification:
A61K 31/4965, C07D 241/26, A61P 11/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP13815644

ARYLALKYL-AND ARYLOXYALKYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

IPC classification:
A61K 31/4965, C07D 241/20, A61P 11/12
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
The patent has been granted
EP13167785

Modulators of ATP-binding cassette transporters

IPC classification:
C07D 471/04, A61P 31/00, A61K 31/404, C07D 405/14, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15184092

3,5-DIAMINO-6-CHLORO-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTA-HYDROXYHEXYL)AMINO)ETHOXY)PHENYL)BUTYL) CARBAMIMIDOYL)PYRAZINE-2-CARBOXAMIDE

IPC classification:
A61P 11/00, A61K 31/4965, C07D 239/48
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION REQUESTED
EP16152270

SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE

IPC classification:
A61P 11/00, A61K 31/47, C07D 215/56
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP11855406

PROCESS FOR PREPARATION OF ACETALS

IPC classification:
B01J 31/02, C07C 41/48, C07D 493/04
Applicant:
Reliance Industries Ltd
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16194421

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES WITH EPITHELIAL SODIUM CHANNEL BLOCKING ACTIVITY

IPC classification:
A61P 11/12, A61K 31/4965, C07D 241/26
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15790211

METHOTREXATE FORMULATION

IPC classification:
A61K 31/519, A61K 9/00, A61K 47/12, A61K 47/10
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Gill Jennings & Every LLP
Status:
Request for examination was made
EP17160386

DEUTERATED DERIVATIVES OF IVACAFTOR

IPC classification:
A61P 11/12, A61K 31/47, C07B 59/00, C07D 215/56
Applicant:
Concert Pharmaceuticals Inc
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
Request for examination was made
EP16849524

ADMINISTRATION OF DEUTERATED CFTR POTENTIATORS

IPC classification:
C07D 215/56, A61K 31/47
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16778627

SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE

IPC classification:
A61K 31/4409, A61K 9/28
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16788877

STABILIZING CAMPTOTHECIN PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 31/4745, A61K 9/127
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16791511

DIBENZO AZEPINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF OTIC DISEASES AND DISORDERS

IPC classification:
A61K 31/55, C07D 223/18
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18173910

INTERMEDIATE COMPOUND FOR PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS

IPC classification:
C07D 405/12, C07D 317/60, C07D 209/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
The application has been published
EP16871328

TOPICAL FORMULATIONS

IPC classification:
C07D 401/00, A01N 37/18, C07K 16/28
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature